Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus

Zheng Quan Toh1,2, Jennie Kosasih,1 Fiona M Russell1,3, Suzanne M Garland4,5, Edward K Mulholland1,6, Paul V Licciardi1,21Infection and Immunity, Murdoch Children’s Research Institute, Parkville, Victoria, Australia; 2Department of Paediatrics, The University of Melbourne, Parkville, Victoria,...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Toh ZQ, Kosasih J, Russell FM, Garland SM, Mulholland EK, Licciardi PV
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Dove Medical Press 2019-07-01
Schriftenreihe:	Infection and Drug Resistance
Schlagworte:	nine-valent HPV vaccine review efficacy and immunogenicity
Online-Zugang:	https://www.dovepress.com/recombinant-human-papillomavirus-nonavalent-vaccine-in-the-prevention--peer-reviewed-article-IDR
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!